Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Hemostatic Disorders × Enoxaparin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 1 Hemostatic Disorders 1

Interventions

edoxaban 1 Enoxaparin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03570281 2018-06-26

ENCHASE

Samsung Medical Center

Phase 2/3 Unknown

Hemostatic Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡